A carregar...
Two preclinical tests to evaluate anticancer activity and to help validate drug candidates for clinical trials
Current approaches to assessing preclinical anticancer activity do not reliably predict drug efficacy in cancer patients. Most of the compounds that show remarkable anticancer effects in preclinical models actually fail when tested in clinical trials. We blame these failures on the complexity of the...
Na minha lista:
| Publicado no: | Oncoscience |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4381701/ https://ncbi.nlm.nih.gov/pubmed/25859551 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|